Urticaria Treatment Market Size, Share, Types, Products, Trends, Growth, Applications and Forecast 2021 to 2027

All News, News

The growing prevalence of urticaria is a key factor expected to drive the market growth during the forecast period, states Fortune Business Insights, in a report, titled “Urticaria Treatment Market Size, Share & Industry Analysis, By Disease Type (Acute Urticaria, Chronic Urticaria), By Drug Type (Antihistamines, H2-blockers, Monoclonal Antibodies, Antidepressants, Other), By Route Of Administration (Oral, Topical, Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others) and Regional Forecast 2020-2027.” The market size is expected to rise tremendously during the forecast period owing to the surging drug approvals.

The emergence of coronavirus has caused the world’s economy to tumble down. We understand that this health emergency has negatively impacted various sectors across the globe. Rising support from governments and several companies can help in the fight against this highly infectious virus. There are some industries that are struggling, and some are thriving. More or less, nearly every sector is estimated to be impacted by this pandemic.

We are perpetually working on our reports to help uplift businesses in this crucial time. Our expertise and experience can offer enormous benefits to help regain during this global pandemic.

Click here to get the short-term and long-term impact of COVID-19 on this Market.

Please visit: https://www.fortunebusinessinsights.com/urticaria-treatment-market-103495

The report on the urticaria treatment market reveals excellent insights into the market, systematic data with detailed analysis, market dynamics & aspects demonstrating development and growth, meticulous information about vital players in the market, and procured statistics about dominant regions

Request sample copy of the Research Report:

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/urticaria-treatment-market-103495

Market Overview:

Growing Awareness about Hypersensitivity to Support Development

The growing cognizance about hypersensitivity and allergies can have a tremendous impact on the global market. The increasing drug approvals for the treatment of urticaria can have a tremendous impact on the market. For instance, In October 2019, JDP Therapeutics received USFDA approval for cetirizine injection (quzyttir) to treat acute urticaria. Urticaria, also known as hives, occurs when the body reacts to an allergen and releases histamine and other chemicals from under the skin’s surface. The histamine and chemicals cause inflammation and fluid to accumulate under the skin, causing wheals. Urticaria can be treated using drugs such as antihistamines, H2-blockers, monoclonal antibodies, antidepressants. However, preference for other treatment options such as homeopathy is expected to dampen the market’s growth.

 

Regional Analysis:

 

Advanced Healthcare Facilities to Influence Growth in North America

 

The market in North America is expected to experience a rapid growth rate during the forecast period owing to the increasing incidence of urticaria in the region. The well-developed healthcare facilities, coupled with significant research investments, will enable growth in the region. According to Allergy & Asthma Network, chronic spontaneous urticaria (CSU) affects approximately 1.6 million people in U.S. High awareness about the disease and improving quality of life can promote North America expansion. Asia Pacific is expected to register the highest CAGR owing to the rising prevalence of urticaria and increasing healthcare expenditure in the region. The market in Latin America and the Middle East & Africa are expected to hold a significant share due to the healthcare sector’s heavy investments.

Key Development:

October 2019: JDP Therapeutics received USFDA approval for cetirizine injection (quzyttir ) for acute urticaria.

September 2018: Novartis AG announced the USFDA approval for Xolair (omalizumab) prefilled syringe formulation for chronic idiopathic urticaria.

 The Report Lists the Key Players in the Urticaria Treatment Market

  • Pfizer Inc.
  • Merck & Co., Inc.
  • Novartis AG
  • Johnson & Johnson Services Inc.
  • Sanofi
  • Genentech, Inc.
  • Teva Pharmaceutical Industries Ltd.

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune – 411045, Maharashtra, India.

Phone:

US:+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: [email protected]

https://industribune.net/